The state-run company Saidal should see an increase in business volume in 2024, and plans are in place for an even bigger leap in 2025 through portfolio diversification as part of a strategy geared at reducing medication imports to the Arab country.
LATEST NEWS
- Brazilian women-led firms design, export burkinis
- Former president of Iraq to lead UNHCR
- IMF forecasts economic growth in Kuwait
- Syria seeks World Bank support for agriculture
- Brazil’s consumption of imports hits 20-year high
- Flamengo defeated by PSG in Qatar tournament
- Flavors of Brazil on Egyptian screens
- UAE opens market to Brazil’s bovine embryos
